Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

by Marius, Trøseid, José R., Arribas, Lambert, Assoumou
Published 2023